This blog is now closed, you can read our full report here
过去几年，跨国药企最迫切的是补充肿瘤管线，及由此衍生的ADC、双抗等Modality（新疗法平台）创新，这恰恰是中国药企过去数年投入最深、产出最密集的赛道。通常，肿瘤领域靶点更明确、入组人群相对较小、疗效衡量清晰，投入产出比更可控。但当前，肿瘤领域赛道已比较拥挤，数据门槛会越来越高，比如更大样本量、更后线治疗、更细分人群等。
。Line官方版本下载对此有专业解读
And then I think elementpath was a thing that was very similar to XPath but not standardized and not as versatile as XPath.
Цены на нефть взлетели до максимума за полгода17:55